What is the appropriate institutional set-up for knowledge generation and use in biotechnology? This paper contributes to the debate by addressing the combined--and potentially conflicting--influence, upon the definition of institutional policies and structures, of two of biotechnology's distinctive features. First, its science-based nature, which defines a set of requirements concerning the production of knowledge and the ability to use it; and second its wide applicability, which requires the consideration of the diversity of technological and organizational capabilities displayed by the whole range of potential biotechnology users. In particular the study investigates whether and to what extent institutional models, whose emergence was largely associated with the behaviour of advanced industrial users from science based sectors, are suitable to the requirements of a more heterogeneous set of biotechnology users, and therefore can withstand a variety of industrial specializations. This issue is addressed empirically by analysing the evolution of the scientific and technological infrastructure of Portuguese biotechnology, as well as the strategic positioning and actual behaviour of individual research and technology organizations. The paper discusses the effectiveness of the current institutional model in Portugal and the implications of a mismatch between biotechnology institutional research frameworks and the industrial structure, for organizations, individual researchers and firms.
No takes yet. Share an insight, caveat, or question.
Fontes et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: